These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 27886686)

  • 1. Preoperative Versus Postoperative Initiation of Warfarin Therapy in Patients Undergoing Total Hip and Knee Arthroplasty.
    Cipriano C; Erdle N; Li K; Curtin B
    Orthop Clin North Am; 2017 Jan; 48(1):9-13. PubMed ID: 27886686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
    Colwell C; Mouret P
    Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of a nomogram and physician-adjusted dosage of warfarin for prophylaxis against deep-vein thrombosis after arthroplasty.
    Anderson DR; Wilson SJ; Blundell J; Petrie D; Leighton R; Stanish W; Alexander D; Robinson KS; Burton E; Gross M
    J Bone Joint Surg Am; 2002 Nov; 84(11):1992-7. PubMed ID: 12429760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of venous thromboembolic disease after total hip and knee arthroplasty.
    Lieberman JR; Hsu WK
    J Bone Joint Surg Am; 2005 Sep; 87(9):2097-112. PubMed ID: 16140827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Response to Warfarin Initiation and the Risk of Venous Thromboembolism After Total Joint Arthroplasty.
    Edelstein AI; Terzaghi C; Nudelman B; Qin C; Kwasny M; Manning DW
    J Am Acad Orthop Surg; 2018 Feb; 26(4):e90-e97. PubMed ID: 29351137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness of warfarin dosing from a nomogram compared with house staff dosing.
    Asnis PD; Gardner MJ; Ranawat A; Leitzes AH; Peterson MG; Bass AR
    J Arthroplasty; 2007 Feb; 22(2):213-8. PubMed ID: 17275636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment.
    Dorr LD; Gendelman V; Maheshwari AV; Boutary M; Wan Z; Long WT
    J Bone Joint Surg Am; 2007 Dec; 89(12):2648-57. PubMed ID: 18056497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DVT prophylaxis: better living through chemistry: affirms.
    Pellegrini VD
    Orthopedics; 2010 Sep; 33(9):642. PubMed ID: 20839678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Warfarin for venous thromboembolism prophylaxis after elective hip or knee arthroplasty: exploring the evidence, guidelines, and challenges remaining.
    Dager WE
    Ann Pharmacother; 2012 Jan; 46(1):79-88. PubMed ID: 22202495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of warfarin for DVT prophylaxis following hip and knee arthroplasty: how often are patients within their target INR range?
    Nam D; Sadhu A; Hirsh J; Keeney JA; Nunley RM; Barrack RL
    J Arthroplasty; 2015 Feb; 30(2):315-9. PubMed ID: 25261182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement.
    Bell GK; Goldhaber SZ
    Vasc Med; 2001; 6(1):23-9. PubMed ID: 11358156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with prolonged wound drainage after primary total hip and knee arthroplasty.
    Patel VP; Walsh M; Sehgal B; Preston C; DeWal H; Di Cesare PE
    J Bone Joint Surg Am; 2007 Jan; 89(1):33-8. PubMed ID: 17200307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of thrombelastography in primary total knee and total hip replacement: a prospective 87 patients study.
    Wang C; Liu Q; Sun L; Dai G
    Blood Coagul Fibrinolysis; 2019 Sep; 30(6):281-290. PubMed ID: 31369408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of discharge and two-week duplex ultrasound screening protocols for deep venous thrombosis detection following primary total joint arthroplasty.
    Dhupar S; Iorio R; Healy WL; Dhimitri K
    J Bone Joint Surg Am; 2006 Nov; 88(11):2380-5. PubMed ID: 17079394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral direct thrombin inhibitor ximelagatran compared with warfarin for the prevention of venous thromboembolism after total knee arthroplasty.
    Colwell CW; Berkowitz SD; Lieberman JR; Comp PC; Ginsberg JS; Paiement G; McElhattan J; Roth AW; Francis CW;
    J Bone Joint Surg Am; 2005 Oct; 87(10):2169-77. PubMed ID: 16203879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DVT prophylaxis in total joint reconstruction.
    Sheth NP; Lieberman JR; Della Valle CJ
    Orthop Clin North Am; 2010 Apr; 41(2):273-80. PubMed ID: 20399366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep vein thrombosis after total knee or hip arthroplasty is associated with increased preoperative calf muscle deoxygenation as measured by near-infrared spectroscopy.
    Yamaki T; Hamahata A; Fujisawa D; Konoeda H; Osada A; Kono T; Nozaki M; Sakurai H
    J Vasc Surg; 2011 Dec; 54(6 Suppl):39S-47S. PubMed ID: 21803529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-molecular-weight heparin prophylaxis: preoperative versus postoperative initiation in patients undergoing elective hip surgery.
    Hull RD; Pineo GF; MacIsaac S
    Thromb Res; 2001 Jan; 101(1):V155-62. PubMed ID: 11342095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplasty.
    Whang PG; Lieberman JR
    Am J Orthop (Belle Mead NJ); 2002 Sep; 31(9 Suppl):31-6. PubMed ID: 12349893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.